SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (686)9/10/1999 12:44:00 AM
From: Larry Liebman  Read Replies (1) | Respond to of 4474
 
Mike..I spoke with COO at ARIA on Tuesday. What I understood him to say was that ARIA had the right to put about $13 million to HMR in ARIA equity in the $8/sh range early in '00. What have you heard?



To: Mike McFarland who wrote (686)9/10/1999 5:25:00 AM
From: SnowShredder  Read Replies (1) | Respond to of 4474
 
Hi Mike,

Interesting link...(don't mind me just thinking online ; )

Are you aware of the work tolerizing APCs to AAV/adenovirus
components so as to significantly reduce host rejection of the
vectors?

I'm not an immunologist (Rick a little help here, please), but wouldn't tolerizing APCs to Ad components be a tad uncomfortable...one could have a cold for a long time...because wouldn't this affect wt Ad too?

Best of Luck, Where'd He Go?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News